Patents by Inventor Michel J. Jung

Michel J. Jung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Triptolide derivatives useful in the treatment of autoimmune diseases
    Patent number: 6004999
    Abstract: The present invention relates to novel triptolide derivatives and a method of treating a patient suffering from an autoimmune disease comprising administering to a patient an effective amount of the novel triptolide derivatives.
    Type: Grant
    Filed: May 12, 1998
    Date of Patent: December 21, 1999
    Assignee: Hoechst Marion Roussel, Inc.
    Inventors: Michel J. Jung, Mahinda Wickramaratne, Michael Hepperle
  • Triptolide derivatives useful in the treatment of autoimmune diseases
    Patent number: 5972998
    Abstract: The present invention relates to novel triptolide derivatives and a method of treating a patient suffering from an autoimmune disease comprising administering to a patient an effective amount of the novel triptolide derivatives.
    Type: Grant
    Filed: May 12, 1998
    Date of Patent: October 26, 1999
    Assignee: Hoechst Marion Roussel, Inc.
    Inventors: Michel J. Jung, Mahinda Wickramaratne, Michael Hepperle
  • Peptidase inhibitors
    Patent number: 5849866
    Abstract: This invention relates to analogs of peptidase substrates in which the amide group containing the scissile amide bond of the substrate peptide has been replaced by an activated electrophilic ketone moiety. These analogs of the peptidase substrates provide specific enzyme inhibitors for a variety of proteases, the inhibition of which will have useful physiological consequences in a variety of disease states.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 15, 1998
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: H. Michael Kolb, Joseph P. Burkhart, Michel J. Jung, Fritz E. Gerhart, deceased, Eugene L. Giroux, Bernhard Neises, Daniel G. Schirlin
  • Peptidase inhibitors
    Patent number: 5496927
    Abstract: This invention relates to analogs of peptidase substrates in which the amide group containing the scissile amide bond of the substrate peptide has been replaced by an activated electrophilic ketone moiety. These analogs of the peptidase substrates provide specific enzyme inhibitors for a variety of proteases, the inhibition of which will have useful physiological consequences in a variety of disease states.
    Type: Grant
    Filed: May 25, 1994
    Date of Patent: March 5, 1996
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: H. Michael Kolb, Joseph P. Burkhart, Michel J. Jung, Fritz E. Gerhart, deceased, Eugene L. Giroux, Bernhard Neises, Daniel G. Schirlin
  • Substituted guanidine and amidine compounds, and fungicidal use
    Patent number: 5376659
    Abstract: The present invention relates to novel substituted guanidine and amidine compounds, their preparation and their use in the kill and control of fungal organisms which infest plants.
    Type: Grant
    Filed: January 14, 1992
    Date of Patent: December 27, 1994
    Assignee: DowElanco
    Inventors: John W. Liebeschuetz, Michel J. Jung
  • Fungicidal compositions, fungicidal compounds, their production and use
    Patent number: 5292743
    Type: Grant
    Filed: April 8, 1992
    Date of Patent: March 8, 1994
    Assignee: DowElanco
    Inventors: John W. Liebeschuetz, Michel J. Jung, Thomas A. K. Smith